tiprankstipranks
Trending News
More News >
Advertisement
Advertisement
Supernus Pharmaceuticals’ Earnings Call: Growth Amid Challenges
PremiumCompany AnnouncementsSupernus Pharmaceuticals’ Earnings Call: Growth Amid Challenges
2M ago
Supernus Pharmaceuticals Reports Strong Q3 2025 Growth
Premium
Company Announcements
Supernus Pharmaceuticals Reports Strong Q3 2025 Growth
2M ago
Supernus Pharmaceuticals: Strong Product Performance and Strategic Management Drive Buy Rating
Premium
Ratings
Supernus Pharmaceuticals: Strong Product Performance and Strategic Management Drive Buy Rating
2M ago
Skyworks upgraded, UnitedHealth downgraded: Wall Street’s top analyst calls
PremiumThe FlySkyworks upgraded, UnitedHealth downgraded: Wall Street’s top analyst calls
3M ago
Supernus initiated with a Buy at BofA
Premium
The Fly
Supernus initiated with a Buy at BofA
3M ago
Supernus Pharmaceuticals’ Real-World Study on ONAPGOTM: A Closer Look
Premium
Company Announcements
Supernus Pharmaceuticals’ Real-World Study on ONAPGOTM: A Closer Look
3M ago
Piper upgrades Supernus on ‘promising’ Onapgo trajectory
PremiumThe FlyPiper upgrades Supernus on ‘promising’ Onapgo trajectory
3M ago
Supernus upgraded to Overweight from Neutral at Piper Sandler
Premium
The Fly
Supernus upgraded to Overweight from Neutral at Piper Sandler
3M ago
Supernus price target raised to $63 from $46 at Cantor Fitzgerald
Premium
The Fly
Supernus price target raised to $63 from $46 at Cantor Fitzgerald
4M ago

Trending

Name
Price
Price Change
S&P 500
Dow Jones
Nasdaq 100